NASDAQ:ARWR Arrowhead Pharmaceuticals - ARWR Earnings Date, Estimates & Call Transcripts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $35.29 +0.30 (+0.86%) (As of 02/1/2023 12:00 AM ET) Add Compare Share Share Today's Range$34.27▼$35.8850-Day Range$28.00▼$40.5652-Week Range$26.81▼$56.25Volume767,956 shsAverage Volume1.10 million shsMarket Capitalization$3.77 billionP/E RatioN/ADividend YieldN/APrice Target$59.22 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Earnings Summary Upcoming Earnings DateFeb. 6ConfirmedActual EPS (Nov. 28) -$0.81 Missed By -$0.24 Consensus EPS (Nov. 28) -$0.57 Last Year's Q4 EPS (11/22/2021) -$0.61Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueARWR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARWR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Arrowhead Pharmaceuticals Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20235($0.81)$1.34$0.25 Q2 20236($1.09)$0.16($0.73) Q3 20236($1.12)$0.15($0.73) Q4 20236($1.12)$0.15($0.77) FY 202323($4.14)$1.80 ($1.97) Get Arrowhead Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ARWR and its competitors with MarketBeat's FREE daily newsletter. ARWR Earnings Date and InformationArrowhead Pharmaceuticals last announced its quarterly earnings data on November 28th, 2022. The biotechnology company reported ($0.81) EPS for the quarter, missing the consensus estimate of ($0.57) by $0.24. The business had revenue of $31.58 million for the quarter, compared to the consensus estimate of $107.60 million. Arrowhead Pharmaceuticals has generated ($1.68) earnings per share over the last year (($1.68) diluted earnings per share). Earnings for Arrowhead Pharmaceuticals are expected to decrease in the coming year, from ($1.16) to ($2.47) per share. Arrowhead Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Monday, February 6th, 2023. Arrowhead Pharmaceuticals will be holding an earnings conference call on Monday, February 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Arrowhead Pharmaceuticals Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 2/6/2023(Confirmed) $1.14 11/28/2022Q4 2022($0.57)($0.81)($0.24)($0.81)$107.60 million$31.58 million8/4/2022Q3 2022($0.45)($0.68)($0.23)($0.68)$52.61 million$32.41 million 5/10/2022Q2 2022$0.39$0.41+$0.02$0.41$122.15 million$151.80 million 2/2/2022Q1 2022($0.22)($0.60)($0.38)($0.60)$67.30 million$27.44 million 11/22/20219/30/2021$0.04($0.61)($0.65)($0.61)$79.31 million$38.28 million 8/4/20216/30/2021($0.08)($0.29)($0.21)($0.29)$50.20 million$45.89 million 5/3/20213/31/2021($0.09)($0.26)($0.17)($0.26)$39.42 million$32.81 million 2/3/202112/31/2020$1.00($0.20)($1.20)($0.20)$157.48 million$21.30 million 11/22/20209/30/2020$0.34($0.48)($0.82)($0.48)$85.13 million$7.63 million 8/5/20206/30/2020($0.07)($0.13)($0.06)($0.13)$38.76 million$27.38 million 5/7/20203/31/2020($0.11)($0.20)($0.09)($0.20)$21.90 million$23.53 million 2/5/202012/31/2019$0.04($0.03)($0.07)($0.03)$36.63 million$29.46 million 11/25/2019Q4$0.14$0.11($0.03)$0.11$36.97 million$43.29 million 8/5/2019Q3 2019$0.34$0.21($0.13)$0.21$59.05 million$42.70 million 5/8/20193/31/2019$0.22$0.24+$0.02$0.24$45.78 million$48.15 million 2/7/201912/31/2018$0.76$0.13($0.63)$0.13$90.88 million$34.66 million12/11/2018Q4 2018($0.17)($0.12)+$0.05($0.12)$3.73 million$11.26 million 8/7/2018Q3 2018($0.19)($0.18)+$0.01($0.18)$0.62 million$0.73 million5/8/2018Q2 2018($0.19)($0.18)+$0.01($0.18)$4.04 million$0.65 million2/9/2018Q1 2018($0.14)($0.18)($0.04)($0.18)$8.71 million$3.51 million 12/12/2017Q4 2017($0.12)($0.14)($0.02)($0.14)$7.32 million$8.71 million8/3/2017Q3 2017($0.13)($0.07)+$0.06($0.07)$5.29 million$9.34 million 5/3/2017Q2 2017($0.1230)($0.08)+$0.0430($0.08)$4.19 million$8.99 million 2/6/2017Q117($0.20)($0.17)+$0.03($0.17)$13.24 million$4.37 million 12/14/2016Q4 2016($0.33)($0.31)+$0.02($0.28)$0.04 million$0.03 million8/9/2016Q316($0.37)($0.32)+$0.05($0.32)$0.05 million$39.58 million5/10/2016Q216($0.37)($0.35)+$0.02($0.35)$0.26 million$0.04 million 2/9/2016Q1($0.41)($0.32)+$0.09($0.32)$0.29 million$0.04 million12/14/2015Q415($0.39)($0.42)($0.03)($0.42)$0.14 million$0.04 million 8/4/2015Q315($0.38)($0.27)+$0.11($0.27)$0.11 million$0.12 million5/11/2015Q214($0.35)($0.33)+$0.02($0.15)$110.00 million$43.75 million 2/9/2015Q114($0.32)($0.41)($0.09)($0.41)$0.24 million$0.17 million11/25/2014Q413($0.25)($0.33)($0.08)($0.24)$0.04 million$0.04 million 8/12/2014Q313($0.22)($0.22)($0.22)$0.04 million$0.04 million 5/6/2014Q2 2014($0.18)($0.31)($0.13)($0.31)$0.05 million$0.04 million2/4/2014Q1 2014($0.18)($0.28)($0.10)($0.28)$0.05 million$0.04 million12/18/2013Q4($0.23)($0.43)($0.20) 8/7/2013Q3 2013($0.22)($0.23)($0.01)($0.23)$0.50 million$0.04 million5/9/2013Q2 2013($0.41)($0.41)($0.41)$0.04 million 2/13/2013Q1 2013($0.33)($0.33) 12/20/2012Q4 2012($0.43)($0.43)8/13/2012Q3 2012($0.71)($0.71)($0.71)5/8/2012Q2 2012($0.44)($0.44)($0.38)2/9/2012Q1 2012($0.25)($0.25)($0.25)12/20/2011Q4 2011($0.39)($0.39)($0.39)8/8/2011Q3 2011($0.20)($0.26)($0.06)($0.27)5/12/2011Q2 2011($0.20)($0.18)+$0.02($0.73)2/10/2011Q1 2011($0.20)($0.20)($0.20)12/22/2010Q4 2010($0.30)($0.28)+$0.02($0.28)8/12/2010Q3 2010($0.50)($0.06)+$0.44($0.06)5/13/2010Q2 2010($0.40)($0.33)+$0.07($0.33)2/11/2010Q1 2010($0.30)($0.30)($0.30)12/22/2009Q4 2009($0.60)($0.60)($0.60)8/10/2009Q3 2009($0.60)($0.60)($0.60)5/15/2009Q2 2009($1.20)($1.20)($1.20)2/9/2009Q1 2009($1.90)($1.90)($1.90)12/15/2008Q4 2008($2.14)($2.14)($2.14)8/11/2008Q3 2008($1.90)($1.90)($1.90)2/11/2008Q1 2008($1.40)($1.40)($1.40)Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions When is Arrowhead Pharmaceuticals's earnings date? Arrowhead Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Monday, February 6th, 2023. Learn more on ARWR's earnings history. Did Arrowhead Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) missed the analysts' consensus estimate of ($0.57) by $0.24 with a reported earnings per share (EPS) of ($0.81). Learn more on analysts' earnings estimate vs. ARWR's actual earnings. How much revenue does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $243.23 million. How much profit does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$176.06 million. ARWR has generated -$1.68 earnings per share over the last four quarters. What is Arrowhead Pharmaceuticals's EPS forecast for next year? Arrowhead Pharmaceuticals's earnings are expected to decrease from ($1.16) per share to ($2.47) per share in the next year. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Should You Take General Motors for a Ride After Earnings?Should You Buy Dividend Achiever Cisco Ahead Of Earnings? After Further Review, Investors Liked Exxon Mobil’s EarningsWill McDonald’s Stock Hit an All-Time HIgh After Earnings?Union Pacific Miss on Earnings, Dividend Still Intact Is Zimmer Biomet a Buy Ahead of Earnings?SoFi Technologies Smashes Earnings but Beware the Fed Decision Upcoming Earnings: Regeneron Pharmaceuticals (2/3/2023)Sanofi (2/3/2023)AON (2/3/2023)Cigna (2/3/2023)Activision Blizzard (2/6/2023)Fiserv (2/7/2023)Vertex Pharmaceuticals (2/7/2023)BP (2/7/2023)Linde (2/7/2023)CME Group (2/8/2023) This page (NASDAQ:ARWR) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.